Structure-based drug design is the design and optimization of a chemical structure with the goal of identifying a compound suitable for clinical testing — a drug candidate. It is based on knowledge of ...
CrowdStrike to buy identity security startup SGNL for $740 million to tackle AI threats CrowdStrike said on Thursday it would buy identity security startup SGNL in a deal valued at $740 million aiming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback